GlassScriptPhysician profile
Laura Mcdermott
NPI 1629122429
$1,375.73
in general payments reported to CMS, 2019-2025
15 companies · $16.79 in 2025
The $16.79 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,030 · 2022: $102 · 2023: $173 · 2024: $53.21 · 2025: $16.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $167.45 | 2021 | |
| Abbvie INC. | $152.56 | 2022-2024 | |
| Lilly USA, LLC | $140.70 | 2021 | |
| Viiv Healthcare Company | $120.58 | 2023 | Dovato |
| Pfizer INC. | $119.90 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $119.64 | 2021 | |
| Novo Nordisk INC | $108.08 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $95.38 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.22 | 2021 | |
| Amgen INC. | $70.21 | 2021 | |
| Amarin Pharma, INC. | $62.15 | 2021 | |
| Merck Sharp & Dohme LLC | $55.88 | 2021 | |
| Abbott Laboratories | $38.28 | 2024-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $33.89 | 2023-2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $11.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Mcdermott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.